UT Health San Antonio-UTSA team studies compounds aimed at brain cancer

January 24, 2023

Basic science generates new drug for treating glioblastoma, the deadliest cancer Contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu Ryan Schoensee, 210-458-6054, ryan.schoensee@utsa.edu SAN ANTONIO (Jan. 24, 2023) — Glioblastoma multiforme (GBM) is an aggressive brain cancer associated with the worst overall survival rates among all human cancers. Only 65% of GBM patients live one year past diagnosis […]

Head x-ray, brain in MRI

Yahoo: An old drug represents a new hope for treating the toughest cancers

December 21, 2022

Ratna K. Vadlamudi, PhD, vice chair for research, Obstetrics & Gynecology, co-leader of the Cancer Development and Progression Program, Mays Cancer Center, and Virginia Kaklamani, MD, Medical Oncology, leader of the Breast Cancer Program, Mays Cancer Center, were quoted in this piece.   Read More

New hope for treating the toughest cancers

December 20, 2022

The Mays Cancer Center at UT Health San Antonio — South Texas’ only National Cancer Institute-Designated Cancer Center — is putting a decades-old antidepressant drug to new use treating breast cancers that don’t respond to existing therapies. Research in the Joe R. and Teresa Lozano Long School of Medicine at UT Health San Antonio provided […]

Ratna Vadlamudi, PhD, lab group

Living Beyond Cancer symposium scheduled for January

December 13, 2022

  Cancer survivors, cancer patients, friends, family and caregivers are invited to attend Living Beyond Cancer A-Z, a free symposium on Jan. 21, put on by the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center. It will feature a full day of learning, empowerment and discovery and will take place […]